Clostridium difficile testing algorithms: What is practical and feasible?

被引:52
作者
Schmidt, Monica L. [1 ]
Gilligan, Peter H. [1 ,2 ,3 ]
机构
[1] Univ N Carolina Hosp, Clin Microbiol Immunol Labs, Chapel Hill, NC 27514 USA
[2] Univ N Carolina, Sch Med, Dept Microbiol Immunol, Chapel Hill, NC 27514 USA
[3] Univ N Carolina, Sch Med, Dept Pathol Lab Med, Chapel Hill, NC 27514 USA
关键词
Clostridium difficile; Rapid tests; Immunoassays; Testing algorithm; POLYMERASE-CHAIN-REACTION; MULTICENTER EVALUATION; ENZYME-IMMUNOASSAY; CYTOTOXICITY ASSAY; TOXIN; INFECTION; CULTURE; DIAGNOSIS; DIARRHEA; ANTIGEN;
D O I
10.1016/j.anaerobe.2009.10.005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
There has been renewed interest in the laboratory diagnosis of Clostridium difficile infections due in large measure to the increase in both numbers and severity of cases of this disease. For the past two decades, enzyme-immunoassays (EIAs) for the detection of first C. difficile toxin A and then toxins A and B have been the most widely used diagnostic test for diagnosis of C. difficile infections. Recently this diagnostic approach has been called into question by the recognition that a screening test which detects glutamate dehydrogenase, a cell wall antigen of C. difficile, was significantly more sensitive than toxins A and B EIAs making it an effective screening test for C. difficile infection. Although sensitive, GDH lacks specificity and so if this test was utilized, a confirmatory test to differentiate false positives from true positives was needed. Studies to date have used cytotoxin neutralization or toxigenic culture as confirmatory tests but both of these have their limitations. A testing algorithm using rapid immunochromatographic devices for detection of GDH and toxins A and B as screening tests will give an accurate test result in approximately 90% of specimens within one hour when using cytotoxin neutralization as a reference method. For the other 10% of specimens, a third test would be needed in the algorithm. This test could be cytotoxin neutralization, toxigenic culture, or PCR for toxin or toxin operon genes. (C) 2009 Published by Elsevier Ltd.
引用
收藏
页码:270 / 273
页数:4
相关论文
共 24 条
[1]   A European survey of diagnostic methods and testing protocols for Clostridium difficile [J].
Barbut, F ;
Delmée, M ;
Brazier, JS ;
Petit, JC ;
Poxton, IR ;
Rupnik, M ;
Lalande, V ;
Schneider, C ;
Mastrantonio, P ;
Alonso, R ;
Kuipjer, E ;
Tvede, M .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (10) :989-996
[2]   Historical perspectives on studies of Clostridium difficile and C difficile infection [J].
Bartlett, John G. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 :S4-S11
[3]  
*COLL AM PATH, 2004, D B BACT SAMPL D 13, P9
[4]  
*COLL AM PATH, 2008, D B BACT SAMPL D 13, P9
[5]   Rapid and reliable diagnostic algorithm for detection of Clostridium difficile [J].
Fenner, Lukas ;
Widmer, Andreas F. ;
Goy, Gisela ;
Rudin, Sonja ;
Frei, Reno .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (01) :328-330
[6]  
GERCLING DN, 1995, INFECT CONT HOSP EP, V16, P459
[7]   Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin a and B enzyme immunoassay for laboratory detection of Clostridium difficile? [J].
Gilligan, Peter H. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (04) :1523-1525
[8]  
GILLIGAN PH, 2008, CLINMICRONET 1031
[9]  
GILLIGAN PH, 2008, TOUCH BRIEF US INFEC, V4, P52
[10]   Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078 [J].
Goorhuis, Abraham ;
Bakker, Dennis ;
Corver, Jeroen ;
Debast, Sylvia B. ;
Harmanus, Celine ;
Notermans, Daan W. ;
Bergwerff, Aldert A. ;
Dekker, Frido W. ;
Kuijper, Ed J. .
CLINICAL INFECTIOUS DISEASES, 2008, 47 (09) :1162-1170